Table 2.
CSAA |
CDAA |
|||
---|---|---|---|---|
WT mice (n = 5) | CCR2−/− mice (n = 5) | WT mice (n = 10) | CCR2−/− mice (n = 10) | |
Body weight, g, start, wk = 0 | 22.0 ± 1.0 | 22.8 ± 0.9 | 22.5 ± 1.1 | 22.3 ± 1.1 |
Body weight, g, end, wk = 22 | 39.4 ± 1.1 | 32.4 ± 2.3* | 39.6 ± 2.0 | 30.6 ± 2.7*† |
Liver weight, g | 2.07 ± 0.03 | 1.25 ± 0.10* | 2.55 ± 0.23* | 1.73 ± 0.32†‡ |
Liver weight, % | 5.26 ± 0.13 | 3.88 ± 0.15* | 6.41 ± 0.29* | 5.65 ± 0.70†‡ |
Epididymal fat, g | 2.33 ± 0.15 | 1.08 ± 0.40* | 2.35 ± 0.30 | 1.11 ± 0.39*† |
Epididymal fat, % | 5.91 ± 0.36 | 3.30 ± 1.08* | 5.94 ± 0.73 | 3.57 ± 1.01*† |
Plasma | ||||
Triglyceride, mg/dl | 32.6 ± 7.8 | 30.0 ± 6.4 | 47.6 ± 9.1* | 37.8 ± 9.5 |
Total cholesterol, mg/dl | 154.0 ± 16.7 | 135.8 ± 16.6 | 86.6 ± 21.6* | 73.4 ± 7.9*‡ |
Free fatty acid, mM | 0.47 ± 0.12 | 0.32 ± 0.71 | 0.49 ± 0.15 | 0.34 ± 0.93† |
HOMA-IR | 2.74 ± 0.50 | 1.28 ± 0.27* | 2.86 ± 0.58 | 1.25 ± 0.17*† |
Values are means ± SD.
Significantly different from wild-type (WT)-choline-supplemented amino acid-defined (CSAA), P < 0.05.
Significantly different from WT-choline-deficient amino acid-defined (CDAA), P < 0.05.
Significantly different from CCR2−/−-CSAA, P < 0.05. HOMA-IR, homeostasis model assessment of insulin resistance.